Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 920 shares at $12.51 ($12K) on 2018-06-05, disclosed to the SEC on 2018-06-11.
Open-market sale of $12k CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |